Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Belén Atienza-Mateo, Diana Prieto-Peña, Esther F. Vicente-Rabaneda, Ricardo Blanco, Miguel A. González-Gay & Santos Castañeda. (2022) Utility of tocilizumab in autoimmune eye diseases. Expert Opinion on Biological Therapy 22:6, pages 789-799.
Read now
Read now
Arash Maleki, Ambika Manhapra, Soheila Asgari, Peter Y. Chang, C. Stephen Foster & Stephen D. Anesi. (2021) Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis. Ocular Immunology and Inflammation 29:1, pages 14-20.
Read now
Read now
Shinji Akioka. (2019) Interleukin-6 in juvenile idiopathic arthritis. Modern Rheumatology 29:2, pages 275-286.
Read now
Read now
Hilal Eser Ozturk, Merih Oray & Ilknur Tugal-Tutkun. (2018) Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy. Ocular Immunology and Inflammation 26:7, pages 1005-1014.
Read now
Read now
Caiyun You, Haitham F Sahawneh, Lina Ma, Buraa Kubaisi, Alexander Schmidt & C Stephen Foster. (2017) A review and update on orphan drugs for the treatment of noninfectious uveitis. Clinical Ophthalmology 11, pages 257-265.
Read now
Read now
Christoph M. E. Deuter, Manfred Zierhut, Annette Igney-Oertel, Theodoros Xenitidis, Alexandra Feidt, Bianka Sobolewska, Nicole Stuebiger & Deshka Doycheva. (2017) Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment. Ocular Immunology and Inflammation 25:2, pages 215-220.
Read now
Read now
Arash Maleki, Halea Meese, Haitham Sahawneh & C. Stephen Foster. (2016) Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis. Expert Review of Clinical Immunology 12:7, pages 775-786.
Read now
Read now
Ivan Foeldvari. (2016) Managing uveitis in patients with juvenile idiopathic arthritis. Expert Opinion on Orphan Drugs 4:7, pages 741-745.
Read now
Read now
Jessica L. Turnier & Hermine I. Brunner. (2016) Tocilizumab for treating juvenile idiopathic arthritis. Expert Opinion on Biological Therapy 16:4, pages 559-566.
Read now
Read now
Khawla Abu Samra, Haitham Sahawneh & C. Stephen Foster. (2016) The role of biologic response modifiers in the management of juvenile idiopathic arthritis associated uveitis: a review. Expert Review of Ophthalmology 11:2, pages 155-163.
Read now
Read now
Valeria Kheir, Jean Vaudaux & Yan Guex-Crosier. (2016) Review of the latest systemic treatments for chronic non-infectious uveitis. Expert Review of Ophthalmology 11:2, pages 111-133.
Read now
Read now
Rowayda M. Amin, Elisabetta Miserocchi, Jennifer E. Thorne, Dana Hornbeak, Douglas A. Jabs & Manfred Zierhut. (2016) Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis. Ocular Immunology and Inflammation 24:1, pages 81-90.
Read now
Read now
Phoebe Lin. (2015) Targeting interleukin-6 for noninfectious uveitis. Clinical Ophthalmology 9, pages 1697-1702.
Read now
Read now
Robert J Barry, Quan Dong Nguyen, Richard W Lee, Philip I Murray & Alastair K Denniston. (2014) Pharmacotherapy for uveitis: current management and emerging therapy. Clinical Ophthalmology 8, pages 1891-1911.
Read now
Read now
Articles from other publishers (30)
Inês Leal, Laura R. Steeples, Shiao Wei Wong, Chiara Giuffrè, Sasa Pockar, Vinod Sharma, Elspeth K.Y. Green, Janine Payne, Nicholas P. Jones, Alice Sieu Eng Chieng & Jane Ashworth. (2024) Update on the systemic management of noninfectious uveitis in children and adolescents. Survey of Ophthalmology 69:1, pages 103-121.
Crossref
Crossref
Claudia Iannone, Luca Marelli, Stefania Costi, Maria Rosa Pellico, Lamberto La Franca, Roberto Caporali & Elisabetta Miserocchi. (2023) Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review. Children 10:3, pages 434.
Crossref
Crossref
Virginia Miraldi Utz, Sheila T. Angeles-Han, Najima Mwase, Amy Cassedy, Theresa Hennard, Daniel J. Lovell, Sarah Lopper, Hermine I. Brunner, Eniolami O. Dosunmu, Alexei A. Grom, Michael Henrickson, Jennifer L. Huggins, Robert A. Sisk, Tracy V. Ting & Adam H. Kaufman. (2022) Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis. American Journal of Ophthalmology 244, pages 183-195.
Crossref
Crossref
Ilaria Maccora, Edoardo Marrani, Maria Vincenza Mastrolia, Ilaria Pagnini & Gabriele Simonini. 2022. Translational Autoimmunity. Translational Autoimmunity
121
137
.
Ilaria Maccora, Ethan S. Sen & Athimalaipet V. Ramanan. (2021) Systemic Immunomodulatory Therapy in Pediatric Uveitis. Advances in Ophthalmology and Optometry 6, pages 87-100.
Crossref
Crossref
Ethan S. Sen & A.V. Ramanan. (2020) Juvenile idiopathic arthritis-associated uveitis. Clinical Immunology 211, pages 108322.
Crossref
Crossref
Carla Gaggiano, Donato Rigante, Gian Marco Tosi, Antonio Vitale, Bruno Frediani, Salvatore Grosso, Claudia Fabiani & Luca Cantarini. (2019) Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review. Clinical Rheumatology 39:2, pages 327-337.
Crossref
Crossref
A. Heiligenhaus, K. Minden, C. Tappeiner, H. Baus, B. Bertram, C. Deuter, I. Foeldvari, D. Föll, M. Frosch, G. Ganser, M. Gaubitz, A. Günther, C. Heinz, G. Horneff, C. Huemer, I. Kopp, C. Lommatzsch, T. Lutz, H. Michels, T. Neß, U. Neudorf, U. Pleyer, M. Schneider, H. Schulze-Koops, S. Thurau, M. Zierhut & H.W. Lehmann. (2019) Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Seminars in Arthritis and Rheumatism 49:1, pages 43-55.
Crossref
Crossref
Valeria Dipasquale, Marco Atteritano, Jlenia Fresta, Irene Castagna & Giovanni Conti. (2019) Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases. Journal of Clinical Pharmacy and Therapeutics 44:3, pages 482-485.
Crossref
Crossref
Ju-Yang Jung, Moon-Young Kim, Chang-Hee Suh & Hyoun-Ah Kim. (2018) Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review. Pediatric Rheumatology 16:1.
Crossref
Crossref
J. Ruiz-Medrano, D. Díaz-Valle, R. Cuiña, J.A. Gegúndez, J. Chhablani, P.D. Majumder & R. Gutierrez-Bonet. (2018) The role of tocilizumab in the treatment of inflammatory diseases of the eye and orbit: A useful alternative. Journal Français d'Ophtalmologie 41:8, pages 759-766.
Crossref
Crossref
Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev & Anna V. Mamutova. (2018) PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY. Current pediatrics 17:3, pages 207-215.
Crossref
Crossref
Marina MesquidaBlanca MolinsVictor LlorençMaría V. Hernández, Gerard EspinosaMaite Sainz de la MazaAlfredo Adán. (2018) TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Retina 38:7, pages 1361-1370.
Crossref
Crossref
Ethan S. Sen & A.V. Ramanan. (2017) Juvenile idiopathic arthritis-associated uveitis. Best Practice & Research Clinical Rheumatology 31:4, pages 517-534.
Crossref
Crossref
Giuseppe Lopalco, Claudia Fabiani, Jurgen Sota, Orso Maria Lucherini, Gian Marco Tosi, Bruno Frediani, Florenzo Iannone, Mauro Galeazzi, Rossella Franceschini, Donato Rigante & Luca Cantarini. (2017) IL-6 blockade in the management of non-infectious uveitis. Clinical Rheumatology 36:7, pages 1459-1469.
Crossref
Crossref
Arjun B. Sood & Sheila T. Angeles-Han. (2017) An Update on Treatment of Pediatric Chronic Non-infectious Uveitis. Current Treatment Options in Rheumatology 3:1, pages 1-16.
Crossref
Crossref
Vanesa Calvo-Río, Montserrat Santos-Gómez, Inmaculada Calvo, M. Isabel González-Fernández, Berta López-Montesinos, Marina Mesquida, Alfredo Adán, María Victoria Hernández, Olga Maíz, Antonio Atanes, Beatriz Bravo, Consuelo Modesto, Gisela Díaz-Cordovés, Natalia Palmou-Fontana, Javier Loricera, M. C. González-Vela, Rosalía Demetrio-Pablo, J. L. Hernández, Miguel A. González-Gay & Ricardo Blanco. (2017) Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients. Arthritis & Rheumatology 69:3, pages 668-675.
Crossref
Crossref
Ethan S. Sen & A. V. Ramanan. 2017. Pediatric Rheumatology. Pediatric Rheumatology
623
638
.
Sarah L. N. Clarke, Ethan S. Sen & Athimalaipet V. Ramanan. (2016) Juvenile idiopathic arthritis-associated uveitis. Pediatric Rheumatology 14:1.
Crossref
Crossref
Lauren A. Henderson, David Zurakowski, Sheila T. Angeles-Han, Andrew Lasky, C. Egla Rabinovich & Mindy S. Lo. (2016) Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric Rheumatology 14:1.
Crossref
Crossref
Nicholas J. D. Gower, Robert J. Barry, Matthew R. Edmunds, Lucy C. Titcomb & Alastair K. Denniston. (2016) Drug discovery in ophthalmology: past success, present challenges, and future opportunities. BMC Ophthalmology 16:1.
Crossref
Crossref
Anne-Mieke J. W. Haasnoot, Jonas J. W. Kuiper, Sanne Hiddingh, Peter A. W. J. F. Schellekens, Wilco de Jager, Saskia M. Imhof, Timothy R. D. J. Radstake & Joke H. de Boer. (2016) Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis & Rheumatology 68:7, pages 1769-1779.
Crossref
Crossref
Sergio Schwartzman & Monica Schwartzman. (2014) The Use of Biologic Therapies in Uveitis. Clinical Reviews in Allergy & Immunology 49:3, pages 307-316.
Crossref
Crossref
Ivan Foeldvari. (2014) Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment. Clinical Reviews in Allergy & Immunology 49:3, pages 271-277.
Crossref
Crossref
Gabriele Simonini, Rolando Cimaz, Gareth T. Jones & Gary J. Macfarlane. (2015) Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review. Seminars in Arthritis and Rheumatism 45:2, pages 238-250.
Crossref
Crossref
Edoardo Marrani, Valeria Paganelli, Cinzia de Libero, Rolando Cimaz & Gabriele Simonini. (2015) Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series. Graefe's Archive for Clinical and Experimental Ophthalmology 253:10, pages 1813-1816.
Crossref
Crossref
Melissa A. Lerman & C. Egla Rabinovich. (2015) The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis. Pediatric Drugs 17:4, pages 283-301.
Crossref
Crossref
Ethan S. Sen, Andrew D. Dick & Athimalaipet V. Ramanan. (2015) Uveitis associated with juvenile idiopathic arthritis. Nature Reviews Rheumatology 11:6, pages 338-348.
Crossref
Crossref
. (2014) Abatacept/tocilizumab. Reactions Weekly 1500:1, pages 5-5.
Crossref
Crossref
Simone AppenzellerRoberto Marini. (2014) Uveíte na artrite idiopática juvenil. Revista Paulista de Reumatologia:2014 jan-mar;13(1), pages 17-20.
Crossref
Crossref